ReviewLeukemia2003

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back.

N von Bubnoff et al.PubMed ↗Publisher ↗

No numbers read from the abstract.